Resilience-Building Interventions for Early Life Adversity
(CARE Trial)
Trial Summary
What is the purpose of this trial?
To examine the behavioral, psychosocial, and biologic impact of resilience-promoting interventions associated with primary care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you or your child have significant medical conditions requiring treatments like immunomodulators, chemotherapy, or hormonal therapy, you may not be eligible to participate.
What data supports the effectiveness of the treatment Caregiver-child Intervention, Enhanced Primary Care, Enhanced Primary Care, E-PRIME for resilience-building in children facing early life adversity?
Research shows that primary care interventions promoting nurturing caregiving relationships can help reduce toxic stress and improve resilience in children. A study on a similar intervention, 'The Resiliency Clinic,' found it feasible and acceptable, with potential positive effects on child and caregiver behavioral health. Additionally, a psychoeducational parenting group in a primary care setting showed significant improvements in family functioning and child behavior, suggesting such interventions can be effective.12345
Is the Resilience-Building Intervention for Early Life Adversity safe for humans?
The studies reviewed focus on the feasibility and acceptability of interventions like Parent Connext and The Resiliency Clinic, which are similar to the Resilience-Building Intervention. These interventions are generally considered safe as they involve psychoeducational support and parent coaching within primary care settings, with no reported adverse effects.23567
How is the treatment Caregiver-child Intervention, Enhanced Primary Care (E-PRIME) different from other treatments for early life adversity?
The Caregiver-child Intervention, Enhanced Primary Care (E-PRIME) is unique because it focuses on building nurturing caregiving relationships and early relational health to mitigate toxic stress in children, using a group-based, psychoeducational approach within primary care settings. This treatment emphasizes the role of caregivers and integrates adversity screening and parent coaching, which is not typically a focus in standard treatments for early life adversity.23568
Research Team
Neeta Thakur, MD, MPH
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This study is for caregivers over 18 and children aged 2-5 who have faced early life adversity. Caregivers must be the primary caregiver, speak English or Spanish, and have regular internet access. Children with significant medical conditions or caregivers with active suicidality are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive one of three resilience-promoting, caregiver-child interventions: Resilience Clinic, Attachment and Biobehavioral Catch-up, or Resiliency Family Program
Follow-up
Participants are monitored for psychosocial, behavioral, and biological outcomes after intervention
Treatment Details
Interventions
- Caregiver-child Intervention
- Enhanced Primary Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Lifelong Medical Care
Collaborator
UCSF Benioff Children's Hospital Oakland
Collaborator
Santa Barbara Neighborhood Clinics
Collaborator
University of California, Santa Barbara
Collaborator
Futures Without Violence
Collaborator